The potential role of vitamin D binding protein in kidney disease: a comprehensive review

References

• Hill NR, Fatoba ST, Oke JL, et al. Global prevalence of chronic kidney disease – a systematic review and meta-analysis. PloS One. 2016;11(7):e0158765.
   PubMed Web of Science ®Google Scholar
• Levin A, Hemmelgarn B, Culleton B, et al. Guidelines for the management of chronic kidney disease. CMAJ. 2008;179(11):1154–1162.
   PubMed Web of Science ®Google Scholar
• Sarafidis PA, Persu A, Agarwal R, et al. Hypertension in dialysis patients: a consensus document by the European renal and cardiovascular medicine (EURECA-m) working group of the European renal association–European dialysis and transplant association (ERA-EDTA) and the hypertension and the kidney working group of the European society of hypertension (ESH)*. Nephrol Dialysis Transplantation. 2017;32(4):620–640. doi: 10.1093/ndt/gfw433
   PubMed Web of Science ®Google Scholar
• Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351(13):1296–1305. doi: 10.1056/NEJMoa041031
   PubMed Web of Science ®Google Scholar
• Moe S, Drüeke T, Cunningham J, et al. Definition, evaluation, and classification of renal osteodystrophy: a position statement from kidney disease: improving global outcomes (KDIGO). Kidney Int. 2006;69(11):1945–1953. doi: 10.1038/sj.ki.5000414
   PubMed Web of Science ®Google Scholar
• Qureshi AR, Alvestrand A, Divino-Filho JC, et al. Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients. J Am Soc Nephrol. 2002;13 Suppl 1(suppl_1):S28–36. doi
   PubMed Web of Science ®Google Scholar
• Franca Gois PH, Wolley M, Ranganathan D, et al. Vitamin D deficiency in chronic kidney disease: recent evidence and controversies. Int J Environ Res Public Health. 2018;15(8):1773. doi: 10.3390/ijerph15081773
   PubMed Web of Science ®Google Scholar
• Ying H-Q, Sun H-L, He B-S, et al. Circulating vitamin D binding protein, total, free and bioavailable 25-hydroxyvitamin D and risk of colorectal cancer. Sci Rep. 2015;5(1):7956. doi: 10.1038/srep07956
   PubMedGoogle Scholar
• Veldurthy V, Wei R, Oz L, et al. Vitamin D, calcium homeostasis and aging. Bone Res. 2016;4(1):16041. doi: 10.1038/boneres.2016.41
   PubMed Web of Science ®Google Scholar
• Saponaro F, Saba A, Zucchi R. An update on vitamin D metabolism. Int J Mol Sci. 2020;21(18):6573. doi: 10.3390/ijms21186573
   PubMed Web of Science ®Google Scholar
• Bikle DD. Vitamin D metabolism, mechanism of action, and clinical applications. Chem Biol. 2014;21(3):319–329. doi: 10.1016/j.chembiol.2013.12.016
   PubMedGoogle Scholar
• Rozmus D, Ciesielska A, Płomiński J, et al. Vitamin D binding protein (VDBP) and its gene polymorphisms—the risk of malignant tumors and other diseases. IJMS. 2020;21(21):7822. doi: 10.3390/ijms21217822
   Google Scholar
• Christakos S, Dhawan P, Verstuyf A, et al. Vitamin D: Metabolism, Molecular Mechanism of Action, and Pleiotropic Effects. Physiol Rev. 2016;96(1):365–408. doi: 10.1152/physrev.00014.2015
   PubMed Web of Science ®Google Scholar
• Vanoirbeek E, Krishnan A, Eelen G, et al. The anti-cancer and anti-inflammatory actions of 1,25(OH)2D3. Best Pract Res Clin Endocrinol Metab. 2011;25(4):593–604. doi: 10.1016/j.beem.2011.05.001
   PubMed Web of Science ®Google Scholar
• Zhang C-J, Zhao D, Yin X, et al. Effects of 1,25(OH)2D3 on proliferation and apoptosis of human glomerular mesangial cells. Am J Transl Res. 2016;8(6):2659–2666.
   PubMed Web of Science ®Google Scholar
• Bikle D, Christakos S. New aspects of vitamin D metabolism and action — addressing the skin as source and target. Nat Rev Endocrinol. 2020;16(4):234–252. doi: 10.1038/s41574-019-0312-5
   PubMed Web of Science ®Google Scholar
• Chun RF, Shieh A, Gottlieb C, et al. Vitamin D binding protein and the biological activity of vitamin D. Front Endocrinol. 2019;10:718. doi: 10.3389/fendo.2019.00718
   PubMed Web of Science ®Google Scholar
• Bouillon R, Schuit F, Antonio L, et al. Vitamin D binding protein: a historic overview. Front Endocrinol. 2019;10:910. doi: 10.3389/fendo.2019.00910
   PubMed Web of Science ®Google Scholar
• Chun RF. New perspectives on the vitamin D binding protein. Cell Biochem Funct. 2012;30(6):445–456. doi: 10.1002/cbf.2835
   PubMed Web of Science ®Google Scholar
• Denburg MR, Bhan I. Vitamin D‐Binding Protein in Health and Chronic Kidney Disease. Semin Dial. 2015;28(6):636–644. doi: 10.1111/sdi.12422
   PubMed Web of Science ®Google Scholar
• Kim HJ, Ji M, Song J, et al. Clinical utility of measurement of Vitamin D-Binding protein and calculation of bioavailable Vitamin D in assessment of Vitamin D status. Ann Lab Med. 2017;37(1):34–38. doi: 10.3343/alm.2017.37.1.34
   PubMed Web of Science ®Google Scholar
• Haddad JG. Transport of vitamin D metabolites: clinical orthopaedics and related research. Clin Orthop Relat Res. 1979;NA(142):249?261. doi: 10.1097/00003086-197907000-00040
   Google Scholar
• Zappulo F, Cappuccilli M, Cingolani A, et al. Vitamin D and the kidney: two players, one console. IJMS. 2022;23(16):9135. doi: 10.3390/ijms23169135
   Google Scholar
• Bikle DD, Schwartz J. Vitamin D binding protein, total and free Vitamin D levels in different physiological and pathophysiological conditions. Front Endocrinol. 2019;10:317. doi: 10.3389/fendo.2019.00317
   PubMed Web of Science ®Google Scholar
• Pop TL, Sîrbe C, Benţa G, et al. The role of Vitamin D and Vitamin D binding protein in chronic liver diseases. Int J Mol Sci. 2022;23(18):10705. doi: 10.3390/ijms231810705
   PubMed Web of Science ®Google Scholar
• Thyer L, Ward E, Smith R, et al. A novel role for a major component of the vitamin D axis: vitamin D binding protein-derived macrophage activating factor induces human breast cancer cell apoptosis through stimulation of macrophages. Nutrients. 2013;5(7):2577–2589. doi: 10.3390/nu5072577
   PubMed Web of Science ®Google Scholar
• Benis K, Schneider G. The effects of vitamin D binding protein-macrophage activating factor and colony-stimulating factor-1 on hematopoietic cells in normal and osteopetrotic rats. Blood. 1996;88(8):2898–2905. doi: 10.1182/blood.V88.8.2898.bloodjournal8882898
   PubMed Web of Science ®Google Scholar
• Yamamoto N, Kumashiro R. Conversion of vitamin D3 binding protein (group-specific component) to a macrophage activating factor by the stepwise action of beta-galactosidase of B cells and sialidase of T cells. J Immunol. 1993;151(5):2794–2802. doi: 10.4049/jimmunol.151.5.2794
   PubMed Web of Science ®Google Scholar
• Bikle DD. Structure and function of the vitamin D-binding proteins [internet]. In: Principles of bone biology. Elsevier; 2020. pp. 713–737. doi:10.1016/B978-0-12-814841-9.00029-4
   Google Scholar
• Gregory KJ, Zhao B, Bielenberg DR, et al. Vitamin D binding protein-macrophage activating factor directly inhibits proliferation, migration, and uPAR expression of prostate cancer cells. PloS One. 2010;5(10):e13428. doi: 10.1371/journal.pone.0013428
   PubMed Web of Science ®Google Scholar
• Li C, Su F, Liang Z, et al. Macrophage M1 regulatory diabetic nephropathy is mediated by m6A methylation modification of lncRNA expression. Mol Immunol. 2022;144:16–25. doi: 10.1016/j.molimm.2022.02.008
   PubMed Web of Science ®Google Scholar
• Speeckaert MM, Speeckaert R, van Geel N, et al. Vitamin D binding protein: a multifunctional protein of clinical importance. Adv Clin Chem. 2014;63:1–57. doi: 10.1016/b978-0-12-800094-6.00001-7
   PubMed Web of Science ®Google Scholar
• Rozmus D, Płomiński J, Augustyn K, et al. rs7041 and rs4588 polymorphisms in vitamin D binding protein gene (VDBP) and the risk of diseases. IJMS. 2022;23(2):933. doi: 10.3390/ijms23020933
   Google Scholar
• Kamboh MI, Ferrell RE. Ethnic variation in vitamin D-binding protein (GC): a review of isoelectric focusing studies in human populations. Hum Genet. 1986;72(4):281–293. doi: 10.1007/BF00290950
   PubMed Web of Science ®Google Scholar
• Speeckaert M, Huang G, Delanghe JR, et al. Biological and clinical aspects of the vitamin D binding protein (gc-globulin) and its polymorphism. Clinica Chimica Acta. 2006;372(1–2):33–42. doi: 10.1016/j.cca.2006.03.011
   PubMed Web of Science ®Google Scholar
• Braun A, Bichlmaier R, Cleve H. Molecular analysis of the gene for the human vitamin-D-binding protein (group-specific component): allelic differences of the common genetic GC types. Hum Genet. 1992;89(4):Internet. doi: 10.1007/BF00194311
   PubMed Web of Science ®Google Scholar
• Constans J, Viau M. Isoelectric focusing of the serum vitamin D transport protein (DBP) and the polymorphism of gc protein. Significance in anthropology. C R Acad Hebd Seances Acad Sci D. 1978;287(8):809–812.
   PubMedGoogle Scholar
• Lauridsen AL, Vestergaard P, Hermann AP, et al. Plasma concentrations of 25-hydroxy-vitamin D and 1,25-dihydroxy-vitamin D are related to the phenotype of gc (vitamin D-Binding protein): a cross-sectional study on 595 early postmenopausal women. Calcif Tissue Int. 2005;77(1):15–22. doi: 10.1007/s00223-004-0227-5
   PubMed Web of Science ®Google Scholar
• Sinotte M, Diorio C, Bérubé S, et al. Genetic polymorphisms of the vitamin D binding protein and plasma concentrations of 25-hydroxyvitamin D in premenopausal women. Am J Clin Nutr. 2009;89(2):634–640. doi: 10.3945/ajcn.2008.26445
   PubMed Web of Science ®Google Scholar
• Yin J, Liu H, Yi X, et al. Genetic variants in the vitamin D pathway genes VDBP and RXRA modulate cutaneous melanoma disease‐specific survival. Pigment Cell Melanoma Res. 2016;29(2):176–185. doi: 10.1111/pcmr.12437
   PubMed Web of Science ®Google Scholar
• Fu L, Yun F, Oczak M, et al. Common genetic variants of the vitamin D binding protein (DBP) predict differences in response of serum 25-hydroxyvitamin D [25(OH)D] to vitamin D supplementation. Clin Biochem. 2009;42(10–11):1174–1177. doi: 10.1016/j.clinbiochem.2009.03.008
   PubMed Web of Science ®Google Scholar
• Kiani A, Mohamadi-Nori E, Vaisi-Raygani A, et al. Vitamin D-binding protein and vitamin D receptor genotypes and 25-hydroxyvitamin D levels are associated with development of aortic and mitral valve calcification and coronary artery diseases. Mol Biol Rep. 2019;46(5):5225–5236. doi: 10.1007/s11033-019-04979-1
   PubMed Web of Science ®Google Scholar
• Newton DA, Baatz JE, Kindy MS, et al. Vitamin D binding protein polymorphisms significantly impact vitamin D status in children. Pediatr Res. 2019;86(5):662–669. doi: 10.1038/s41390-019-0322-y
   PubMed Web of Science ®Google Scholar
• Lizana J, Olsson I. High resolution isoelectric focusing in a Narrow pH Interval for the phenotyping of vitamin D-Binding protein (gc-globulin). Clin Chem Lab Med. 1984;22(8): doi:10.1515/cclm.1984.22.8.545.
   Google Scholar
• Lauridsen AL, Vestergaard P, Nexo E. Mean serum concentration of vitamin D-binding protein (gc globulin) is related to the gc phenotype in women. Clin Chem. 2001;47(4):753–756. doi: 10.1093/clinchem/47.4.753
   PubMed Web of Science ®Google Scholar
• Woloszczuk W. Determination of vitamin D binding protein by Scatchard analysis and estimation of a free 25-hydroxy-vitamin D index. Clinica Chimica Acta. 1985;145(1):27–35. doi: 10.1016/0009-8981(85)90016-6
   PubMed Web of Science ®Google Scholar
• Boonen S, Lysens R, Verbeke G, et al. Relationship between age-associated endocrine deficiencies and muscle function in elderly women: a cross-sectional study. Age Ageing. 1998;27(4):449–454. doi: 10.1093/ageing/27.4.449
   PubMed Web of Science ®Google Scholar
• Hamashima Y, Kanazawa T, Hirata A, et al. Measurement of vitamin D-binding protein in pleural fluids and sera by means of a turbidimetric immunoassay measuring system. Clinica Chimica Acta. 2002;321(1–2):23–28. doi: 10.1016/S0009-8981(02)00089-X
   PubMed Web of Science ®Google Scholar
• Jørgensen CS, Schiødt FV, Dahl B, et al. Comparison of rocket and crossed immuno‐electrophoresis assays for determination of the level of actin complexing of gc globulin. Scand J Clin Lab Invest. 2007;67(7):767–777. doi: 10.1080/00365510701326909
   PubMed Web of Science ®Google Scholar
• Lauridsen AL, Aarup M, Christensen AL, et al. Sensitive automated ELISA for measurement of vitamin D-Binding protein (gc) in human urine. Clin Chem. 2005;51(6):1016–1018. doi: 10.1373/clinchem.2004.045658
   PubMed Web of Science ®Google Scholar
• Cleal JK, Day PE, Simner CL, et al. Placental amino acid transport may be regulated by maternal vitamin D and vitamin D-binding protein: results from the Southampton Women’s survey. Br J Nutr. 2015;113(12):1903–1910. doi: 10.1017/S0007114515001178
   PubMed Web of Science ®Google Scholar
• Cillero AI, Martínez-Morillo E, Mantecón L, et al. Phenotyping and relative quantification of vitamin D binding protein in a paediatric population by using liquid chromatography–tandem mass spectrometry. Ann Clin Biochem. 2019;56(1):56–63. doi: 10.1177/0004563218780135
   PubMed Web of Science ®Google Scholar
• Hoofnagle AN, Eckfeldt JH, Lutsey PL. Vitamin D–binding protein concentrations quantified by mass spectrometry. N Engl J Med. 2015;373(15):1480–1482. doi: 10.1056/NEJMc1502602
   PubMed Web of Science ®Google Scholar
• Powe CE, Evans MK, Wenger J, et al. Vitamin D-binding protein and vitamin D status of black Americans and white Americans. N Engl J Med. 2013;369(21):1991–2000.
   PubMed Web of Science ®Google Scholar
• Diaz-Riera E, García-Arguinzonis M, López L, et al. Vitamin D Binding Protein and Renal Injury in Acute Decompensated Heart Failure. Front Cardiovasc Med. 2022;9:829490. doi: 10.3389/fcvm.2022.829490
   PubMed Web of Science ®Google Scholar
• Chen H, Ni L, Wu X. Performance of urinary vitamin D-binding protein in diabetic kidney disease: a meta-analysis. Ren Fail. 2023;45(2):2256415. doi: 10.1080/0886022X.2023.2256415
   PubMed Web of Science ®Google Scholar
• Zeng J, Wen Q, Rong R, et al. Vitamin D-Binding protein is a potential urinary biomarker of irbesartan treatment response in patients with IgA nephropathy. Genet Test Mol Biomarkers. 2016;20(11):666–673.
   PubMed Web of Science ®Google Scholar
• Go DJ, Lee JY, Kang MJ, et al. Urinary vitamin D-binding protein, a novel biomarker for lupus nephritis, predicts the development of proteinuric flare. Lupus. 2018;27(10):1600–1615. doi: 10.1177/0961203318778774
   PubMed Web of Science ®Google Scholar
• Doorenbos CRC, de Cuba MM, Vogt L, et al. Antiproteinuric treatment reduces urinary loss of vitamin D-binding protein but does not affect vitamin D status in patients with chronic kidney disease. J Steroid Biochem Mol Biol. 2012;128(1–2):56–61.
   PubMed Web of Science ®Google Scholar
• Prytuła A, Wells D, McLean T, et al. Urinary and dialysate losses of vitamin D-binding protein in children on chronic peritoneal dialysis. Pediatr Nephrol. 2012;27(4):643–649. doi: 10.1007/s00467-011-2045-0
   PubMed Web of Science ®Google Scholar
• Grzegorzewska AE, Ostromecki G, Mostowska A, et al. Clinical aspects of vitamin D-binding protein gene polymorphisms in hemodialysis patients. Pol Arch Med Wewn. 2015;125(1–2):8–17. doi: 10.20452/pamw.2636
   PubMed Web of Science ®Google Scholar
• Speeckaert MM, Glorieux GL, Vanholder R, et al. Vitamin D binding protein and the need for vitamin D in hemodialysis patients. J Ren Nutr. 2008;18(5):400–407. doi: 10.1053/j.jrn.2008.04.013
   PubMed Web of Science ®Google Scholar
• Alarcón R D, Alburquerque-González B, Á F-V, et al. Pharmacogenetic role of vitamin D-binding protein and vitamin D receptor polymorphisms in the treatment response of dialysis patients with secondary hyperparathyroidism. Nephrol Dialysis Transplantation. 2022;37(4):792–795.
   PubMed Web of Science ®Google Scholar
• Fowlkes JL, Bunn RC, Cockrell GE, et al. Dysregulation of the Intrarenal Vitamin D Endocytic Pathway in a nephropathy-prone mouse model of type 1 diabetes. Exp Diabetes Res. 2011;2011:1–7. doi: 10.1155/2011/269378
   Google Scholar
• Gharib A, Askary A, Almehmadi M, et al. Vitamin D and hypoxia-inducible factor (HIF-1α) serum levels as markers for progression of nephropathy in type 2 diabetic patients. Clin Lab. 2022;68(4/2022): doi:10.7754/Clin.Lab.2021.210540
   Web of Science ®Google Scholar
• Mahadevappa R, Nielsen R, Christensen EI, et al. Megalin in acute kidney injury: foe and friend. Am J Physiol Renal Physiol. 2014;306(2):F147–F154. doi: 10.1152/ajprenal.00378.2013
   PubMed Web of Science ®Google Scholar
• Leheste J-R, Rolinski B, Vorum H, et al. Megalin knockout mice as an animal model of low molecular weight proteinuria. Am J Pathol. 1999;155(4):1361–1370. doi: 10.1016/S0002-9440(10)65238-8
   PubMed Web of Science ®Google Scholar
• Thrailkill KM, Nimmo T, Bunn RC, et al. Microalbuminuria in type 1 diabetes is associated with enhanced excretion of the endocytic multiligand receptors megalin and Cubilin. Diabetes Care. 2009;32(7):1266–1268. doi: 10.2337/dc09-0112
   PubMed Web of Science ®Google Scholar
• Gekle M. Transforming growth factor-beta1 reduces megalin- and cubilin-mediated endocytosis of albumin in proximal-tubule-derived opossum kidney cells. Journal Of Physiology. 2003;552(2):471–481. doi: 10.1113/jphysiol.2003.048074
   PubMed Web of Science ®Google Scholar
• Hosojima M, Sato H, Yamamoto K, et al. Regulation of megalin expression in cultured proximal tubule cells by angiotensin II type 1A receptor- and insulin-mediated signaling cross talk. Endocrinology. 2009;150(2):871–878. doi: 10.1210/en.2008-0886
   PubMed Web of Science ®Google Scholar
• Chaykovska L, Heunisch F, von Einem G, et al. Urinary vitamin D binding protein and KIM-1 are potent new biomarkers of major adverse renal events in patients undergoing coronary angiography. PloS One. 2016;11(1):e0145723. doi: 10.1371/journal.pone.0145723
   PubMed Web of Science ®Google Scholar
• Mirković K, Doorenbos CRC, Dam WA, et al. Urinary vitamin D binding protein: a potential novel marker of renal interstitial inflammation and fibrosis. PloS One. 2013;8(2):e55887. doi: 10.1371/journal.pone.0055887
   PubMed Web of Science ®Google Scholar
• Al Ghadeer HA, AlRamadan MS, Al Amer MM, et al. Vitamin D Serum Levels in Type 2 Diabetic Patients: A Cross-Sectional Study. Cureus. 2022; doi:10.7759/cureus.22558.
   Google Scholar
• Ashraf AP, Huisingh C, Alvarez JA, et al. Insulin resistance indices are inversely associated with vitamin D binding protein concentrations. J Clin Endocrinol Metab. 2014;99(1):178–183. doi: 10.1210/jc.2013-2452
   PubMed Web of Science ®Google Scholar
• Huang H-Y, Lin T-W, Hong Z-X, et al. Vitamin D and Diabetic Kidney Disease. IJMS. 2023;24(4):3751. doi: 10.3390/ijms24043751
   Google Scholar
• Yanagawa H, Suzuki H, Suzuki Y, et al. A panel of serum biomarkers differentiates IgA nephropathy from other renal diseases. PloS One. 2014;9(5):e98081. doi: 10.1371/journal.pone.0098081
   PubMed Web of Science ®Google Scholar
• Zhao Y-F, Zhu L, Liu L-J, et al. Pathogenic role of glycan-specific IgG antibodies in IgA nephropathy. BMC Nephrol. 2017;18(1):301. doi: 10.1186/s12882-017-0722-3
   PubMedGoogle Scholar
• Wu L, Liu D, Xia M, et al. Immunofluorescence deposits in the mesangial area and glomerular capillary loops did not affect the prognosis of immunoglobulin a nephropathy except C1q: a single-center retrospective study. BMC Nephrol. 2021;22(1):43. doi: 10.1186/s12882-021-02237-w
   PubMed Web of Science ®Google Scholar
• Chen WT, Yamaoka K, Nakajima S, et al. Evaluation of vitamin D-binding protein and vitamin D metabolite loss in children on continuous ambulatory peritoneal dialysis. Bone Miner. 1992;17(3):389–398.
   PubMedGoogle Scholar
• Vahdat S. Vitamin D and kidney diseases: a narrative review. Int J Prev Med. 2020;11:195. doi: 10.4103/ijpvm.IJPVM_54_19
   PubMed Web of Science ®Google Scholar
• Hsu S, Vervloet MG, De Boer IH. Vitamin D in CKD: an unfinished story. Am J Kidney Diseases. 2023;82(5):512–514. doi: 10.1053/j.ajkd.2023.07.005
   PubMed Web of Science ®Google Scholar
• Bai X, Luo Q, Tan K, et al. Diagnostic value of VDBP and miR‑155‑5p in diabetic nephropathy and the correlation with urinary microalbumin. Exp Ther Med. 2020;20(5):1–1. doi: 10.3892/etm.2020.9214
   PubMed Web of Science ®Google Scholar
• Vu D, Sakharkar P, Tellez-Corrales E, et al. Association of vitamin D binding protein polymorphism with long-term kidney allograft survival in Hispanic kidney transplant recipients. Mol Biol Rep. 2013;40(2):933–939. doi: 10.1007/s11033-012-2134-6
   PubMed Web of Science ®Google Scholar